COVID-19 patients in the Philippines may get early access to Merck & Co.’s yet to be approved anti-viral treatment pill starting in November.
Filipino-owned importer MedEthix Inc and distributor JackPharma Inc said in a joint statement yesterday that they will bring molnupiravir to hospitals in the Philippines as early as next month.
Already a subscriber? Log in.
Win a prize this Mother's Day by subscribing to our annual plan now! T&C applies.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!